What are Pancreatic enzyme replacement therapy drugs?

Pancreatic enzyme replacement therapy drugs are pharmacologic agents that share a common mechanism (typically targeting Triglycerides and dietary lipids). 3 are currently marketed, with 4 more in clinical development.

What are the marketed Pancreatic enzyme replacement therapy drugs?

Marketed Pancreatic enzyme replacement therapy drugs include Pancrelipase Capsules, creon 35.000 Ph.U (R), Panzytrat 25.000 FIP-E units of Lipase.

Pancreatic enzyme replacement therapy

3 marketed 4 in Phase 3

This page covers all Pancreatic enzyme replacement therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Triglycerides and dietary lipids.

Targets

Triglycerides and dietary lipids

Marketed (3)

Pancrelipase Capsules · Ohio State University · Gastroenterology
Pancrelipase is a mixture of pancreatic enzymes (lipase, protease, and amylase) that replaces deficient endogenous pancreatic enzymes to restore normal digestion of fats, proteins, and carbohydrates.
creon 35.000 Ph.U (R) · Hospital Clinico Universitario de Santiago · Gastroenterology
Creon is a pancreatic enzyme replacement therapy that supplies lipase, amylase, and protease to aid digestion of fats, carbohydrates, and proteins in patients with pancreatic insufficiency.
Panzytrat 25.000 FIP-E units of Lipase · Foundation for Liver Research · Gastroenterology
Panzytrat is a pancreatic enzyme replacement therapy containing lipase that aids in the digestion and absorption of dietary fats.

Phase 3 pipeline (4)

Creon® 10000 · Abbott · Gastroenterology
Creon 10000 is a pancreatic enzyme replacement therapy that supplies lipase, protease, and amylase to aid digestion of fats, proteins, and carbohydrates in patients with pancreatic insufficiency.
Pancreatic enzyme capsules · Asian Institute of Gastroenterology, India · Gastroenterology
Pancreatic enzyme capsules replace deficient pancreatic enzymes (amylase, lipase, protease) to restore normal digestion in patients with pancreatic insufficiency.
PANCRECARB® (pancrelipase) · Digestive Care, Inc. · Gastroenterology
Pancrelipase is a pancreatic enzyme replacement therapy that supplies lipase, protease, and amylase to aid digestion of fats, proteins, and carbohydrates in patients with pancreatic insufficiency.
Creon N · Abbott · Gastroenterology
Creon N is a pancreatic enzyme replacement therapy that provides lipase, protease, and amylase to aid digestion of fats, proteins, and carbohydrates in patients with pancreatic insufficiency.